ConductScience.org, home

Paper42007396

Peptide-Based Therapeutics for Alzheimer's Disease: Medicinal Chemistry, AI-Guided Computational Design, and Blood-Brain Barrier Delivery.

Al Khzem AH and 1 other. Drug Des Devel Ther, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Peptide-Based Therapeutics for Alzheimer's Disease: Medicinal Chemistry, AI-Guided Computational Design, and Blood-Brain Barrier Delivery. Papers, record 42007396. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42007396

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Peptide-Based Therapeutics for Alzheimer's Disease: Medicinal Chemistry, AI-Guided Computational Design, and Blood-Brain Barrier Delivery.
PubMed
Journal
Drug Des Devel Ther
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-10-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Al Khzem AHAbdulaziz Hhttps://orcid.org/0009-0004-0079-8646
2Gomaa MSMohamed Shttps://orcid.org/0000-0003-2112-9092

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug DesignMajor topic
Blood-Brain BarrierMajor topic
Drug Delivery SystemsMajor topic
Alzheimer DiseaseMajor topic
PeptidesMajor topic
Chemistry, Pharmaceutical
Artificial Intelligence
Humans
Disease Models, Animal
Animals

Source PubMed

Download CSV of topics

References161

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134959346Protease-Resistant Peptides for Targeting and Intracellular Delivery of Therapeutics.Pharmaceutics2021https://conductscience.org/library/papers/34959346PubMed
239877373Mitochondrial dysfunction in Alzheimer's disease: a key frontier for future targeted therapies.Front Immunol2024https://conductscience.org/library/papers/39877373PubMed
339074563Emerging role of Metformin in Alzheimer's disease: A translational view.Ageing Res Rev2024https://conductscience.org/library/papers/39074563PubMed
422236121Peptides for therapy and diagnosis of Alzheimer's disease.Curr Pharm Des2012https://conductscience.org/library/papers/22236121PubMed
539997662Topic Issue: "Translational Advances in Neurodegenerative Dementias".Neurol Int2025https://conductscience.org/library/papers/39997662PubMed
629186912Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer's Disease Therapeutic Agents.Mar Drugs2017https://conductscience.org/library/papers/29186912PubMed
740732273From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40732273PubMed
835298810Dynamics of Amyloid Formation from Simplified Representation to Atomistic Simulations.Methods Mol Biol2022https://conductscience.org/library/papers/35298810PubMed
939653296Peptide-based inhibitors and nanoparticles: Emerging therapeutics for Alzheimer's disease.Int J Pharm2025https://conductscience.org/library/papers/39653296PubMed
1039814713Illuminating the impact of N-terminal acetylation: from protein to physiology.Nat Commun2025https://conductscience.org/library/papers/39814713PubMed
1130895453PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution.Drug Deliv Transl Res2019https://conductscience.org/library/papers/30895453PubMed
1231879928Peptidomimetic Synthesis: Drug Discovery for Alzheimer's Disease.Methods Mol Biol2020https://conductscience.org/library/papers/31879928PubMed
1323428883Approaches for enhancing oral bioavailability of peptides and proteins.Int J Pharm2013https://conductscience.org/library/papers/23428883PubMed
1425225492Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System.Front Endocrinol (Lausanne)2014https://conductscience.org/library/papers/25225492PubMed
1523173066The role of molecular simulations in the development of inhibitors of amyloid β-peptide aggregation for the treatment of Alzheimer's disease.ACS Chem Neurosci2012https://conductscience.org/library/papers/23173066PubMed
1640494420Fighting Alzheimer's naturally: Peptides as multitarget drug leads.Bioorg Med Chem Lett2025https://conductscience.org/library/papers/40494420PubMed
1739560122Recent advances in peptide macrocyclization strategies.Chem Soc Rev2024https://conductscience.org/library/papers/39560122PubMed
1832695874Alzheimer's disease drug development pipeline: 2020.Alzheimers Dement (N Y)2020https://conductscience.org/library/papers/32695874PubMed
1931742308Real-time monitoring of solid-phase peptide synthesis using a variable bed flow reactor.Chem Commun (Camb)2019https://conductscience.org/library/papers/31742308PubMed
2037002811Peptides for trans-blood-brain barrier delivery.J Labelled Comp Radiopharm2023https://conductscience.org/library/papers/37002811PubMed

See all 161 referencesDownload CSV of references

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene
OXT5020PubTator's text mininghttps://conductscience.org/library/genes/5020NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42007396

GET https://conductscience.org/api/papers/v1/42007396/references?page=2